About Abba
David Gordon: Experienced Biotechnology and Life Sciences Practice Attorney in Baltimore, Maryland, United States
David Gordon is a seasoned attorney specializing in biotechnology and life sciences practice. With over two decades of legal experience, he has represented numerous clients in the complex world of biotech litigation and transactions.
Practice Areas
- Biotechnology and Life Sciences Practice
- Commercial Finance Law
- Corporate Law
- Mergers and Acquisitions Law
- Sercurities / Capital Markets Law
- Sercurities Regulation
Awards
- Lawyer of the Year: Securities / Capital Markets Law, Baltimore (2013)
- Recognized: Biotechnology and Life Sciences Practice, 2007
- Recognized: Commercial Finance Law, 2008
- Recognized: Corporate Law, 2009
- Recognized: Mergers and Acquisitions Law, 2010
- Recognized: Securities / Capital Markets Law, 2011
- Recognized: Securities Regulation, 2012
- Special Focus: Biotechnology, Special Focus: Corporate, Special Focus: Corporate Compliance, Special Focus: Corporate Finance, Special Focus: Corporate Governance, Special Focus: COVID-19, Special Focus: Information Technology, Special Focus: Intellectual Property, Special Focus: Mergers & Acquisitions, Special Focus: Securities, Special Focus: Technology, Special Focus: Transactions, Special Focus: Venture Capital, 2007
Firms
- Gordon Feinblatt LLC
Affiliations
- Baltimore Bar Association
- Maryland State Bar Association
- International Life Sciences Law Group
Languages
Recognized Since
David Gordon has been recognized as a Recognized Attorney in Best Attorney USA since 2007.
Born and raised in Baltimore, Maryland, David brings a deep understanding of the local legal landscape to his clients. He is particularly known for his expertise in biotech litigation and corporate transactions, where he represents major pharmaceutical companies, medical device manufacturers, and life sciences startups with confidence and skill.
Practice Areas
Education
Awards & Recognition
- Lawyer of the Year: Securities / Capital Markets Law, Baltimore (2013)
- Recognized: Biotechnology and Life Sciences Practice
- Recognized: Commercial Finance Law
- Recognized: Commercial Litigation
- Recognized: Corporate Law
- Recognized: Mergers and Acquisitions Law
- Recognized: Securities / Capital Markets Law
- Recognized: Securities Regulation
- Special Focus: Biotechnology
- Special Focus: Corporate
- Special Focus: Corporate Compliance
- Special Focus: Corporate Finance
- Special Focus: Corporate Governance
- Special Focus: COVID-19
- Special Focus: Information Technology
- Special Focus: Intellectual Property
- Special Focus: Mergers & Acquisitions
- Special Focus: Securities
- Special Focus: Technology
- Special Focus: Transactions
- Special Focus: Venture Capital